A randomized hybrid type I effectiveness-implementation study of an ehealth delivery alternative for cancer genetic testing for hereditary cancer predisposition (EREACH)

Ended Cooperative Agreement Awarded Last action

Award ID
U01CA243702
Recipient
Awarding agency
Obligated
$3,916,305

Award facts

Completion date
Place of performance
Pennsylvania, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$871
Amendment $731,103
Amendment $0
Amendment $785,824
Amendment $0
Amendment $785,755
Amendment $0
Amendment $800,208
Original award $814,286

Subawards

Subrecipient Amount Awarded
Fox Chase Cancer Center "Linda Fleisher, Ph.D., MPH, will be responsible for assisting the research team in recruitment strategies, process and implementation evaluation, as well as… $75,000
Fox Chase Chemical Diversity Center Inc. Linda Fleisher, Ph.D., MPH, will be responsible for assisting the research team in recruitment strategies, process and implementation evaluation, as well as… $91,146
Thomas Jefferson University Under the proposed subcontract, Thomas Jetterson university w111 worK w1tn university or t-'ennsy1 serving as a study site for the project, A Randomized… $17,032

Quick answers

Who received award U01CA243702?

U01CA243702 was awarded to The Trustees Of The University Of Pennsylvania by National Cancer Institute (National Institutes of Health) on September 17, 2020.

How much is award U01CA243702 worth?

$3,916,305 has been obligated on U01CA243702.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award